Irinotecan Hydrochloride Structural Formula (Irinotecan 01)
Irinotecan Hydrochloride Injection, Solution
Product Images NDC 61703-349
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 61703-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Survival Second-line Irinotecan Vs Best Supportive Care (bsc) Study 7 (Irinotecan 02)
Figure 2. Survival Second-line Irinotecan Vs Infusional 5-fu Study 8 (Irinotecan 03)
This text seems to be describing a figure labeled as "Figure 2" that shows survival rates for a specific treatment (Irinotecan/5-FU/LV) compared to another treatment (5-FULV or SFULV). The figure was likely obtained from a study labeled as "Study 2" and includes data points at specific intervals of time (marked on the x-axis). The text also includes a reference to a statistical test called the "log-rank test".*
Hospira Logo (Irinotecan 04)
Principal Display Panel (2 mL Vial Label)
Principal Display Panel (2 mL Vial Carton)
Principal Display Panel (5 mL Vial Label)
Principal Display Panel (5 mL Vial Carton)
This is a warning label for a cytotoxic agent called Irinotecan Hydrochloride Injection, used only for intravenous purposes. The solution must be diluted before use and must be stored and protected properly. The label provides information on the required dosage and the contents of the solution in each milliliter. It also includes manufacturer and distributor information as well as a product code.*
Principal Display Panel (25 mL Vial Label)
This is a label of a 5 mL vial containing a sterile cytotoxic agent, which must be diluted before use and can only be used intravenously. The National Drug Code is 61703-349-09. The vial contains 20 mg/mL of the agent. The label contains a cautionary message regarding the cytotoxic nature of the agent. There are also several alphanumeric codes and abbreviations, as well as some unidentifiable characters.*
Principal Display Panel (25 mL Vial Carton)
This text contains information about a medication called Irinotecan Hydrochloride Injection, for intravenous use only. The medicine is sold in a 100mg/5mL single-dose vial and contains Irinotecan Hydrochloride Trifhydrate. The usual dosage and administration is explained in the package insert provided with the product. It must be diluted with 5% Dextrose Injection or 0.9% Sodium Chloride Injection. The medication should be stored between 20°-25°C (66°-77°F) and protected from light and freezing. The product cannot be reused and should be discarded after a single use. The text also includes the supplier's information and a caution about the drug being a cytotoxic agent.*
Irinotecan 11
Not available.*
Irinotecan 12
This is a description for a drug called "Irinotecan Hydrochloride Trihydrate." This medication is provided in a single-dose vial and is for intravenous use only. The drug contains "sorbitol powder, 45 mg; lactic acid, 09 mg" and "Water for injection, USP q.5." The drug has to be diluted before use and is usually diluted with "sodium chloride injection" to provide final concentration ranging between 0.12101.1 mg/ml. There is no antimicrobial agent contained in the drug, and it should be used once and discarded. The usual dosage of the medication is available in the package insert. The drug has to be stored at 20°-25°C (68°-77°F). The company producing this drug is Lake Forest and it is located in the US.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
